Results 101 to 110 of about 1,764,628 (294)

Non-expected Utility, Saving, and Portfolios [PDF]

Existing findings suggest that standard, frictionless, expected-utility models have difficulty accounting for average and for median holdings of wealth and of risky assets, partly as a result of the largely unexplained limited proportion of stockholders ...
Christis Hassapis, Michael Haliassos
core  

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Preferences for shifts in probabilities and expected utility theory

Estudios Económicos, 2007
Las preferencias definidas sobre loterías inducen preferencias sobre cambios en probabilidades. Definimos el axioma de independencia para preferencias definidas sobre cambios en probabilidades. Al usar esta versión del axioma de independencia construimos
David Cantalá
doaj  

Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches. [PDF]

Pharmacoeconomics, 2022
Elbasha EH.
europepmc   +1 more source

Rejecting Small Gambles Under Expected Utility [PDF]

This paper contributes to an important recent debate around expected utility and risk aversion. Rejecting a gamble over a given range of wealth levels imposes a lower bound on risk aversion.
Ignacio Palacios-Huerta, Oscar Volij, Roberto Serrano   +2 more
core  

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Effects of the GM Controversy on Iowa Corn-Soybean Farmers' Acreage Allocation Decisions

Journal of Agricultural and Resource Economics, 2003
Prior to the 2000 planting season, some industry observers predicted acreage of genetically modified crops would decline dramatically. However, actual 2000 plantings presented a puzzle.
Corinne E. Alexander, Jorge Fernandez-Cornejo, Rachael E. Goodhue   +2 more
doaj   +1 more source

Range dependent expected utility theory based model for NIMBY conflicts in China: An evolutionary game analysis. [PDF]

PLoS One, 2022
Zhao H, Wang W, Zhang M.
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Assessing expected utility and profitability to support decision-making for disease control strategies in ornamental heather production. [PDF]

Precis Agric, 2022
Ruett M, Dalhaus T, Whitney C, Luedeling E.   +3 more
europepmc   +1 more source